Saturday, October 10, 2026

Hippo Holdings ($HIPO): The Insurtech That Stopped Chasing Hype and Started Making Money

Hippo’s insurance platform posted 61% premium growth, a 95.8% combined ratio and a fifth profitable quarter as it shifted toward carrier and MGA fee income.

HIPO $906M

Substack von Philipp Oct 10 7 clicks

Oct 9 HY $573M

Hyster Yale (HY) Multibagger potential as confluence of negatives subside. Attractive after markets part services model

Calvin Blissett 1 click

Oct 8 NAMM $62M

Namib Minerals: Research Note

Atrium Research - Equity Research

From X

@TimyanBankAlert Jul 31 1 click

Timyan Bank Alert on X

Bank investors need this. Please don’t go. $CCB $GBFH $FFBB $UBAB $SLBK https://t.co/ibodMsCRRH https://t.co/rmGbDGHcpL

@bank_reg Jul 31

Bank Reg Blog on X

Clearly not the main headline from $CCB's earnings yesterday, but still likely of interest to some readers https://t.co/07bcFN06pR https://t.co/1hdpGgNIPH

@mavix_leon Jul 31 2 clicks

mavix on X

I just published my Portfolio Update for July '26. It includes: ▫️My current Portfolio & position sizes ▫️Earnings Update about $EVO, $BRM.V, $ALENO.PA, -undisclosed- ▫️Recent news & information about $LEAT, $CIRC.MI, $SLYG, $4058, $EVO Link for the blog in Bio 😊 https://t.co/7eVa84MGbr

@Mike10947310 Jul 30

Mike on X

If anyone likes playing busted biotechs I think $FULC is worth a look. Trading at -EV but with Tang upping stake and with very traditionally aligned insiders who tend to return capital and own a large amount of the name (incentivized). There has been - more than usual - a spate recent shells being used for reverse mergers.

@Mike10947310 Jul 30

Mike on X

$LRCX is $RELL biggest customer and has a record up day today, on the back of strong earnings from Richardson. https://t.co/Jowt0qmxXX

@ActAccordingly Jul 30 1 click

PAA Research on X

A name for @dirtcheapstocks and @dirtcheapbanks... $ETD. $600 mkt cap, $133MM in cash, no debt. Generated $40MM+ in cash flow last year. They also have extensive real estate holdings (unencumbered) which could be worth $175-$275MM. They pay a regular dividend of $0.39/quarter which is about a 7.0% yield. For the past 6-years they've used any excess FCF to pay special dividends to shareholders. The stock trades at 1.5x book (which is clearly understated). Seems like someone should buy this biz.

@DOMOCAPITAL Jul 30

DOMO Capital Management, LLC on X

$ALTO $GPRE E15 👀👀 "Senate Republicans will include language to permanently allow year-round sales of E15 fuel in the farm bill they plan to mark up next Thursday, according to two people familiar with the plans."

@TimyanBankAlert Jul 29 2 clicks

Timyan Bank Alert on X

Activist investor prods Washington bank to sell $CSHX https://t.co/XjIjYSAw1Y via @bankingdive

Lesaka: A $4.69 Stock With a $20–30 Case

Lesaka CEO Ali Mazanderani has bought more than $10 million of stock while pursuing a $20 to $30 valuation case through targeted…

LSAK $405M

Mispriced Assets Oct 8 5 clicks

What I’ve Been Up To

Cogent Communications and AI data-center bottlenecks feature in a newsletter update on recruiting, financial media and conference takeaways.

CCOI $430M

Stock Thoughts Oct 7 2 clicks

Lesaka: Why He's Betting Big | Ali Mazanderani | Ep. 5

Lesaka’s executive chairman has invested more than $10 million personally and targets EPS compounding above 40% through consumer, merchant…

LSAK $405M

Mispriced Assets Oct 7 2 clicks

VersaBank: Expensive, But Growth Still Justifies A Buy

VersaBank's Q3 revenue rose 23% and adjusted net income 27%, while a 2.19% net interest margin and 19.15x forward earnings temper its 2027…

VBNK $702M

Grassroots Trading Oct 6

OMSE 2026-10-05

The Monday Morning Briefing: AI Drives Everything, Yet ROI on Massive Capex Remains Uncertain

Latticework’s briefing questions AI capex returns while featuring Close Brothers, Green Landscaping and OMS Energy Technologies.

OMSE $183M

Latticework by MOI Global Oct 5 2 clicks

Pyxis Oncology: Better Runway Is Bullish For MICVO's Remaining R&D

Pyxis Oncology's recent financing extends MICVO's runway to clinical milestones as the oncology candidate works to establish a safe,…

PYXS $168M

Myriam Alvarez Oct 4 2 clicks

EVI Industries. Margin inflection or fake out?

EVI Industries says its ERP and service-platform build is largely complete, testing whether 10.8% revenue growth can finally outpace…

EVI $238M

Kairos Research Oct 2 2 clicks

Single Stock Spotlight #16: Huckleberry.AI (HUCK)

Huckleberry.AI trades near $3.30 against $221 million of cash and $900 million-plus of NOLs after selling its operating business, creating…

HUCK $147M

Hidden Rock Capital's Newsletter Oct 2 5 clicks

Not So Fast

Entravision, the portfolio’s largest position, fell more than 40% from its highs as Q3 returns dropped to 37.8% YTD.

EVC $598M

The Mikro Kap Oct 1 1 click

Washington Trust Bancorp: 100-Year Track Record Of Dividends Supports A 6% Yield

Washington Trust Bancorp offers a 5.8% dividend yield, with C&I loan growth supporting ROE despite 40% commercial real estate loan…

WASH $560M

Sorrento Research Oct 1

BNTC · long

Benitec Biopharma INC

Benitec Biopharma's BB-301 gene therapy is in a Phase 1b/2a trial for an ultra-rare muscular dystrophy.

BNTC $316M

Value Investors Club Jul 12

Solid Power Still Has Promise

Solid Power reported a $0.11 Q2 loss and $419.3 million of cash, with its electrolyte pilot line and BMW and SK On validation central to…

SLDP $518M

Quad 7 Capital Oct 5 2 clicks

Zentek Research Note

Zentek shipped its first ZenGUARD air-filter order to a Canadian federal facility as its Albany graphite PEA confirmed a US$3.85 billion…

ZTEKF $58M

Atrium Research - Equity Research Sep 30 1 click

NASDAQ:YB 10% dividend, 2x P/E, 30% growth, AI beneficiary, secular tailwinds, founder CEO I think is as good as Bezos/Walton

Yuanbao pairs a 10.2% dividend and cash exceeding its market value with 33.5% first-half profit growth from AI-enabled Chinese insurance…

YB $526M

Calvin Blissett Sep 30 4 clicks

3 Mergers and 1 Liquidation in the Danger Zone

Stratus Properties liquidates Austin real estate below projected distributions, while Atlantic Lithium and Intermex await approvals for…

STRS $143MIMXI $376M

Triple S Special Situations Investing Sep 30

💥Yield!💥

Beyond Meat’s Q2 2026 revenue fell 8.2% as U.S. retail and foodservice volumes declined, while a flatter, not inverted, Treasury curve…

BYND $132M

PETITION Sep 30

Cullinan Therapeutics: Compelling Pullback For CLN-978's Potential In Autoimmune Diseases

Cullinan Therapeutics plans December 2026 autoimmune updates for CLN-978, while zipalertinib awaits an FDA decision in previously treated…

CGEM $907M

Myriam Alvarez Sep 29 2 clicks

VersaBank: The Bank Behind the Bank – How a Canadian Branchless Pioneer Wants to Make Asset-Backed Securities Obsolete

VersaBank uses cash holdbacks and put-backs to buy point-of-sale loan cash flows, with C$7 billion in assets and AI-enabled real-time…

VBNK $702M

Substack von Philipp Sep 26 7 clicks

Updates

FGPR remains on track, PRTH's management buyout is set at $8.05, and microcap RAVE is described as cheap.

FGPR $248MPRTH $644M

Nat Stewart - Stock Picking Newsletter Sep 25 9 clicks

Is The Bond Market Running On Empty?

U.S. Treasury yields are testing credit and equity markets, while the discussion also targets recent changes at Glass House (GLAS).

GLAS $401M

WHAT ARE WE DOING? “Contrarians At The Gate” Sep 25 1 click

Saturday, October 10, 2026

Timyan Bank Alert on X

Bank Reg Blog on X

mavix on X

Mike on X

Mike on X

PAA Research on X

DOMO Capital Management, LLC on X

Timyan Bank Alert on X

Investor Letters

Publications we follow

Newsletters 106

YouTube 4

Blogs 17

Seeking Alpha 47 of 223

X accounts we follow

Investor letters we follow

Sectors